A feasibility study to investigate the use of a bupivacaine-collagen implant (XaraColl) for postoperative analgesia following laparoscopic surgery | Zendy

Lisa Hemsen | Zendy; Susan Cusack | Zendy; Harold S. Minkowitz | Zendy; Michael E. Kuss | Zendy

Open Access

A feasibility study to investigate the use of a bupivacaine-collagen implant (XaraColl) for postoperative analgesia following laparoscopic surgery

Author(s) -

Lisa Hemsen,

Susan Cusack,

Harold S. Minkowitz,

Michael E. Kuss

Publication year - 2013

Publication title -

journal of pain research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.888

H-Index - 49

ISSN - 1178-7090

DOI - 10.2147/jpr.s40158

Subject(s) - medicine , bupivacaine , anesthesia , surgery , implant , opioid , laparoscopic surgery , inguinal hernia , randomized controlled trial , postoperative pain , laparoscopy , hernia , receptor

XaraColl, a collagen-based implant that delivers bupivacaine to sites of surgical trauma, has been shown to reduce postoperative pain and use of opioid analgesia in patients undergoing open surgery. We therefore designed and conducted a preliminary feasibility study to investigate its application and ease of use for laparoscopic surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research